Know Cancer

or
forgot password

A UW Phase II Trial of Multi-catheter HDR Brachytherapy Following Lumpectomy for Early Stage Breast Breast Cancer


Phase 2
18 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

A UW Phase II Trial of Multi-catheter HDR Brachytherapy Following Lumpectomy for Early Stage Breast Breast Cancer


Inclusion Criteria:



- Invasive breast cancer or DCIS, tumor stage of Tis, T1, T2 if lesion is < 3 cm, N0 or
N1 if 1-3 + nodes with no extracapsular extension

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To determine if brachytherapy will produce non-inferior local regional control at 5 years post treatment when compared to historical results of conventional XRT

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Rakesh Patel, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wisconsin, Madison

Authority:

United States: Institutional Review Board

Study ID:

RO04102

NCT ID:

NCT00214149

Start Date:

October 2004

Completion Date:

October 2010

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location
University of Wisconsin Hospital and Clinics Madison, Wisconsin  53792-0001